EFFECT OF SCENARIO-BASED SIMULATION ON BASIC LIFE SUPPORT SKILLS AND SELF-EFFICACY IN NURSING STUDENTS (SBS-BLS)

February 4, 2026 updated by: Ekrem EKER, Bartın Unıversity

THE EFFECT OF SCENARİO-BASED SİMULATİON METHOD ON NURSİNG STUDENTS' BASİC LİFE SUPPORT PRACTİCE SKİLLS AND SELF-EFFİCACY LEVELS: A CONTROLLED EXPERİMENTAL STUDY

This study aimed to evaluate the effectiveness of scenario-based simulation in improving nursing students' adult basic life support (ABLS) skills and self-efficacy. Ethical approval was obtained from the Bartın University Social and Human Sciences Ethics Committee, and institutional permission was granted. The study was conducted with students from the Department of Nursing at the Faculty of Health Sciences, Bartın University, between October and December 2025.

The sample size was determined based on the literature using an alpha level of 0.05, an effect size of 0.63, and a statistical power of 85%. A total of 50 students who met the inclusion criteria were randomly assigned to either the experimental or control group. All participants were informed about the study and provided written informed consent.

Data were collected using the Student Information Form, the Adult Basic Life Support Knowledge Level Assessment, the Adult Basic Life Support Skill Performance Assessment Form, and the Student Self-Efficacy Scale. All students received a 90-minute theoretical ABLS training delivered by an experienced researcher. Following the theoretical session, the control group practiced ABLS using the demonstration method on a feedback-enabled manikin, while the experimental group practiced using scenario-based simulation. Both applications were conducted under academic supervision.

Students' knowledge, skill performance, and self-efficacy levels were assessed immediately after training, after the first application, and at a one-month follow-up. Data were analyzed using SPSS version 29.0. No significant difference was found between the groups in knowledge scores immediately after training. After the first application, no significant differences were observed in knowledge or self-efficacy levels; however, skill performance scores were significantly higher in the control group. At the one-month follow-up, a significant decline in skill performance was observed in the control group, whereas the experimental group maintained their performance levels.

These findings indicate that scenario-based simulation supports the long-term retention of practical ABLS skills. Therefore, integrating simulation-based methods into adult basic life support education in nursing programs is recommended.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study aimed to examine the effectiveness of scenario-based simulation methods in improving nursing students' adult basic life support skills and self-efficacy levels. Ethical approval was obtained from the Bartın University Social and Human Sciences Ethics Committee, and official permission was granted by the relevant institution. The study was conducted with students from the Department of Nursing at the Faculty of Health Sciences, Bartın University. Data were collected between October and December 2025. The sample size was calculated based on the literature with an alpha level of 0.05, an effect size of 0.63, and a statistical power of 85 percent. The study was completed with 50 students who met the inclusion criteria and were randomly assigned to either the experimental group or the control group. All participants were informed about the research process, and their voluntary informed consent was obtained. Data were collected using the Student Information Form, the Adult Basic Life Support Knowledge Level Assessment, the Adult Basic Life Support Skill Performance Assessment Form, and the Student Self-Efficacy Scale. All students received a 90-minute theoretical adult basic life support training provided by a researcher with professional experience in the field. Following the theoretical training, students in the control group performed adult basic life support practices using the demonstration method on a feedback-enabled training manikin under academic supervision. Students in the experimental group performed adult basic life support practices using scenario-based simulation under the same supervision. Students' knowledge levels, skill performance, and self-efficacy levels were evaluated immediately after the training, during the first application, and at a one-month follow-up. Data analysis was performed using SPSS version 29.0. The findings indicated no significant difference between the groups in knowledge scores immediately after training. While no significant differences were observed in knowledge and self-efficacy levels after the first application, skill performance scores were significantly higher in the control group. However, at the one-month follow-up, a significant decline in skill performance was observed in the control group, whereas no significant decrease was found in the experimental group. These results suggest that scenario-based simulation provides a more sustainable improvement in practical skill performance. Therefore, it is recommended that adult basic life support education in nursing programs be supported with simulation-based methods.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
50

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
      • Bartın, Turkey (Türkiye), 74100
        • Bartin University Faculty of Health Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Voluntarily agreeing to participate in all stages of the research (pre-test - training - post-test, etc.),
  • Actively enrolled in a Nursing Undergraduate Program,
  • Able to read and understand Turkish,
  • Not having any physical or cognitive disability that would prevent participation in practical training,
  • Not having received any prior training in TYD (Basic Nursing Education).

Exclusion Criteria:

  • Having received any non-research-related training on TYD that you can conduct research on previously,
  • Being a graduate of a Health Vocational High School or a graduate of any associate's or bachelor's degree program in the health field,
  • Not having registered for courses in the relevant period or having suspended the semester,
  • Not regularly attending training sessions during the research process,
  • Having serious health problems that will increase the data collection period,
  • Incomplete completion of pre-test or post-test forms.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Arm 1: Scenario-Based Simulation Group
Participants in this group received scenario-based simulation training on basic life support.
Other: Scenario-Based Simulation Training
Scenario-based simulation training was provided to improve basic life support skills and self-efficacy among nursing students.
Other Names:
  • Simülasyon Tabanlı Temel Yaşam Desteği Eğitimi
Active Comparator: Arm 2: Standard Training Group
Participants in this group received standard theoretical and practical training on basic life support according to the nursing curriculum.
Other: Standard Basic Life Support Training
Hemşirelik müfredatına uygun olarak verilen standart teorik ve pratik temel yaşam desteği eğitimi.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Basic Life Support Practice Skills
Time Frame: Baseline (pre-test), immediately after the intervention (post-test), and 1-month follow-up
Basic life support practice skills were assessed using a standardized skills performance checklist.
Baseline (pre-test), immediately after the intervention (post-test), and 1-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Bartın Unıversity

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: EKER, Bartin University Faculty of Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 1, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 1, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 17, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 17, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 26, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 6, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 4, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • BARUN-MSC-TYD-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Basic Life Support Training

Clinical Trials on Scenario-Based Simulation Training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings